Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Isotechnika -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (67)	5/26/2003 7:08:58 PM
From: Icebrg	Respond to of 285

Peter >> Note that 247, because it is an immunosuppressant, is always going to be reserved for serious psoriasis, even if there are no kidney tox issues. So it wouldn't necessarily completely displace the biologics.>> I believe that the biologics due to their very high cost will be used only as a last resort treatment for severe cases. There are a number of treatment options that for cases which are not so severe and which will give satisfactory results. Anyhow, the potential market for the biologics seems to be shrinking while at the same time the number of participants is increasing. I don't see this as an major growth area for the biotechs. Perhaps MEDI did the right thing holding back further development of MEDI 507. One of the first treatments to be used was evidently tar. Erik "Topical tars were once used as an essential component of the Goeckerman regimen in which patients applied crude coal tar in the hospital for most of the day, removing the tar only before ultraviolet light treatments. Use of tars slowed when it was shown that emollients such as petrolatum were equally effective when used in conjunction with UVB light. Apart from their limited effectiveness, the staining caused by tars has greatly limited their use. Attempts to make tar preparations that are not greasy and do not stain the skin have not been successful, partly because the messiest tars seem to be the most effective."